(Q51571293)
Statements
Optimizing the absorption of valspodar, a P-glycoprotein modulator, Part I: Selecting an oral formulation and exploring its clinical pharmacokinetics/dynamics. (English)
1 reference
E A Mueller
1 reference
J M Kovarik
1 reference
Y Uresin
1 reference
S S Preisig-Flückiger
1 reference
S Hensel
1 reference
P W Lücker
1 reference
B Holt
1 reference
1 November 1997
1 reference
37
1 reference
11
1 reference
1001-1008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference